Cyclophosphamide Tablet
Product Images NDC 10019-984

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 10019-984). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structure Formula (Image 01)

Chemical structure of Cyclophosphamide monohydrate showing the phosphorus atom bonded to oxygen and nitrogen atoms, with a 2-chloroethyl side chain and a six-membered ring including oxygen.*

FDA Label Image

Cyclo Representative Container Label Ndc 10019-982-09 (Image 02)

Label for Cyclophosphamide tablets, USP 25 mg, oral dosage form, containing 100 tablets. The label specifies that it is a cytotoxic agent, with handling warnings, and is manufactured for Baxter Healthcare Corporation. Storage instructions note to keep between 20°C to 25°C (68°F to 77°F). The label includes NDC 10019-982-09 and states the product is made in Italy and is a product of Germany.*

FDA Label Image

Cyclo Representative Carton Label Ndc 10019-982-01 1 Of 2 (Image 03)

Packaging label for Cyclophosphamide tablets USP 25 mg, a cytotoxic agent. The label indicates 100 tablets per container, prescription only, and advises wearing gloves when handling. It includes storage instructions at 20°C to 25°C and manufacturer details: Baxter Healthcare Corporation, Deerfield, IL, made in Italy, product of Germany.*

FDA Label Image

Cyclo Representative Carton Label Ndc 10019-982-01 2 Of 2 (Image 04)

Packaging label for Cyclophosphamide tablets, USP 25 mg, oral tablet form. The label indicates it is a cytotoxic agent and advises wearing gloves when handling the container and tablets. The package contains 100 tablets and is marked Rx only. The labeler is Baxter Healthcare Corporation with manufacturing noted in Italy and product origin Germany. The NDC on the label is 10019-982-01.*

FDA Label Image

Cyclo Representative Container Label Ndc 10019-984-09 (Image 05)

Cyclophosphamide tablets, USP 50 mg oral tablets packaging label showing 100 tablets. The label includes warnings for cytotoxic handling, dosage instructions not to cut or crush tablets, storage temperature range, and manufacturer information for Baxter Healthcare Corporation. NDC 10019-984-09 is displayed.*

FDA Label Image

Cyclo Representative Carton Label Ndc 10019-984-01 1 Of 2 (Image 06)

Packaging label for Cyclophosphamide tablets USP 50 mg, an oral cytotoxic agent manufactured for Baxter Healthcare Corporation. The label indicates 100 tablets per container, with warnings to wear gloves when handling and instructions to swallow tablets whole without cutting, chewing, or crushing. Storage recommendation is 20°C to 25°C (68°F to 77°F). Product made in Germany.*

FDA Label Image

Cyclo Representative Carton Label Ndc 10019-984-01 2 Of 2 (Image 07)

Cyclophosphamide tablets, USP 50 mg packaging label for oral tablets, 100 count, produced by Baxter Healthcare Corporation. The label includes a warning that it is a cytotoxic agent requiring gloves when handling, and the product is prescription only. The packaging states that the tablets are made in Italy and are a product of Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.